Form 4 for PGEN PRECIGEN, INC.
Accepted 2022-01-06 00:00:00 ET · period of report 2022-01-04 · accession 0000950103-22-000271 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-01-06 | 2022-01-05 | PGEN | Sabzevari Helen | Pres, CEO, Dir | S - Sale+OE | $3.59 | -6,960 | 734.1K | -0.9% | -$25.0K |
| D | 2022-01-06 | 2022-01-04 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | — | +17.7K | 741.1K | +2% | — |
| D | 2022-01-06 | 2022-01-04 | PGEN | Sabzevari Helen | Pres, CEO, Dir | M - OptEx | $0.00 | -17.7K | 17.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-05 | S | D | 1,357 | $3.59 | 739,753 | D | — | — | |
| 2 | Common | Common Stock | 2022-01-04 | M | A | 17,667 | — | 741,110 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
| 3 | Common | Common Stock | 2022-01-05 | S | D | 5,603 | $3.59 | 734,150 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2022-01-04 | M | D | 17,667 | $0.00 | 17,665 | D | — · — to — | 17,667 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. (F3) The RSUs were granted on January 4, 2019 and January 25, 2019 and the remaining RSUs vest on January 4, 2023. |